← Back to elysiumhealth newsletters

NAD+ keeps your heart's clock running

4:03 PM (Yesterday)elysiumhealth
Elysium
Plus: major new cholesterol guidelines, a surprising genetics finding, and more.
ELYSIUM
Welcome to the ‌April‌ edition of The Abstract. ‌April‌ 25 is DNA Day—marking the 1953 publication of the double helix—and this month's issue arrives with genetic news to match. Three of our five studies touch on heredity and epigenetics: a landmark framework for why cells lose their molecular identity with age, new evidence that a single chemical exposure can leave a biological mark lasting 20 generations, and a study that may fundamentally change how much credit we give our genes for how long we live. Rounding out the issue: what NAD+ has to do with your heart's internal clock, and why your cholesterol target just got lower.
Eleven major medical organizations, including the American Heart Association and American College of Cardiology, just rewrote the cholesterol playbook. The new guidance recommends starting LDL testing at age 10, beginning treatment by 30, and hitting lower targets than previously advised—below 70 for those with elevated risk, below 55 for anyone who's already had a cardiac event. The shift reflects a growing consensus that lifetime LDL exposure, not just your numbers today, is what drives heart disease risk.
The Expert’s Take:
“As a cardiologist, I emphasize to my patients that cholesterol is an important risk factor for heart disease, but only one risk factor. Equally important are blood pressure, blood sugar, body weight, and especially lifestyle including diet, physical activity, and not smoking. The single most powerful path to good health is through a healthy lifestyle, which not only avoids the side effects of medications but has numerous additional benefits, such as on energy, mood, and sleep.”
Dariush Mozaffarian, M.D., Dr.P.H.
Director, Food is Medicine Institute
Distinguished Professor, Dean Emeritus, Jean Mayer Professor of Nutrition, Professor of Medicine
Member of the Elysium Scientific Advisory Board
Basis
TERM OF THE MONTH
SIRT1
/ˈsər-tü-ən ˈwən/
SIRT1—sirtuin 1—is an NAD+-dependent enzyme that acts as one of the body's master regulators of cellular health. SIRT1 belongs to a family of proteins called sirtuins whose foundational role in longevity was first discovered by Elysium’s chief scientist and co-founder Leonard Guarente, Ph.D., and his lab at MIT in the late 1990s. SIRT1 helps control gene expression, DNA repair, inflammation, and metabolic function by removing acetyl groups from proteins, effectively switching biological programs on or off. SIRT1 is a core regulatory component of the circadian clock machinery, helping to coordinate the daily rhythms that keep organs like the heart running in sync. Because SIRT1 requires NAD+ to function, the well-documented decline in NAD+ with age means SIRT1 activity falls too—contributing to disrupted rhythms, impaired repair, and accelerating cellular dysfunction. It sits at the intersection of the epigenetic and metabolic hallmarks of aging.
AGING 101
What is your circadian rhythm—and how does it impact your health?
Circadian rhythms are the 24-hour biological cycles that govern sleep, metabolism, hormone release, and more. When they fall out of sync—due to light exposure, shift work, or aging—the effects ripple across nearly every system in the body. Here's what's happening, and how to keep your clock running on time. (Read more)
 
 
E
 
fb   insta   in
 
© ‌2026‌ Elysium Health Inc., ‌434‌ Broadway, ‌Floor 2,‌ New York, ‌NY 10013‌

Call or text: (888) 220-6436        care@elysiumhealth.com        Unsubscribe        View in Your Browser

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to screen, diagnose, treat, cure, or prevent any disease or condition or assess risk of any disease or condition. If pregnant or nursing, consult with your physician before using.
 
 

Latest Emails from elysiumhealth

See more